Abstract
Human papillomavirus (HPV) vaccines are currently utilised globally in national immunisation programmes. In July 2017, a national HPV vaccine programme for men who have sex with men (MSM) was initiated across Scotland with vaccine being offered in the sexual health clinic setting. During the first year of this targeted vaccination programme, there were 5,905 individuals who received at least one dose of HPV vaccine, representing 63.7% of eligible MSM attendees in this period. Vaccine uptake was relatively stable across all age groups (range 49.8-55.5%). The vaccination programme appears to have dovetailed well with pre-existing sexual health services and appears to be popular with MSM attending the service. The MSM HPV vaccine programme is a robust adjunct to the national girls programme but gender-neutral immunisation will reduce stigma and inequality in HPV-driven disease
Original language | English |
---|---|
Pages (from-to) | 5513-5514 |
Number of pages | 2 |
Journal | Vaccine |
Volume | 37 |
Issue number | 37 |
Early online date | 10 Dec 2018 |
DOIs | |
Publication status | Published - 3 Sept 2019 |
Keywords
- HPV
- MSM
- uptake
- Vaccine
- Sexual health
ASJC Scopus subject areas
- General Veterinary
- Public Health, Environmental and Occupational Health
- Infectious Diseases
- Molecular Medicine
- General Immunology and Microbiology